Sekce: Daily overview

Selection from Decision-Making Practice - 8

The State Institute for Drug Control (SÚKL) has rejected a request by the marketing authorization holder (MAH) of an orphan medicinal product (OMP) to suspend the proceedings on the setting of the...
Pharmeca a.s. 04/23/2025
Sekce: Daily overview

Selection from Decision-Making Practice - 7

Use of Subjective Parameters in Administrative Proceedings
Pharmeca a.s. 04/17/2025
Sekce: Daily overview

Ministry of Health Opinion on Medicines for Rare Diseases

The Ministry of Health of the Czech Republic has published its opinion on the use of a medicinal product for rare diseases (LPVO) with reimbursement granted under Section 39da as a comparator in...
MZ ČR 04/10/2025
Sekce: Daily overview

Selection from Decision-Making Practice - 6

Removal of the Prescription Symbol “A”
Pharmeca a.s. 04/09/2025
Sekce: Daily overview

Selection from Decision-Making Practice - 5

The Institute may not conduct its own pharmacoeconomic analyses
Pharmeca a.s. 04/02/2025
Sekce: Daily overview

VZP Requests Submission of EMDN Codes

VZP requests that all applicants submit EMDN codes for all medical devices (ZÚM) listed in the VZP Reimbursement Catalogue.
VZP 04/01/2025
Sekce: Daily overview

Selection from Decision-Making Practice - 4

Ensuring the Right to Full Reimbursement for Medicinal Products Listed in Annex No. 2
Pharmeca a.s. 03/26/2025
Sekce: Daily overview

Selection from Decision-Making Practice - 3

Health Insurance Companies' Statement on the Unacceptability of Budget Impact.
Pharmeca a.s. 03/19/2025